Post Reply
221-240 of 288
Come quickily and buy...last call....leaving soon.
Come la, join here...
Hold on tight...moving soon
hopefully....
Looks like this project still have legs to go...
Just reported on SGX. Project Super is still ongoing, need more time for negotiations.
Seriously buy some this week to keep...huat big big
no specific date for annoucement, just that we like to speculate 1 month time frame.
But pretty good accumulation at 0.32 to 0.345 range. Just hold tight.
sp71171 ( Date: 15-Jan-2021 11:07) Posted:
too quiet...hoping for some actions as they are due to update announcement on 18 jan......
Invest1 ( Date: 14-Jan-2021 11:32) Posted:
| Looks like this stock needs some noise....huat ar.. |
|
|
|
Any link/ source regarding to 18jan?
thks.!
sp71171 ( Date: 15-Jan-2021 11:07) Posted:
too quiet...hoping for some actions as they are due to update announcement on 18 jan......
Invest1 ( Date: 14-Jan-2021 11:32) Posted:
| Looks like this stock needs some noise....huat ar.. |
|
|
|
too quiet...hoping for some actions as they are due to update announcement on 18 jan......
Invest1 ( Date: 14-Jan-2021 11:32) Posted:
| Looks like this stock needs some noise....huat ar.. |
|
let' s buy some...
Have a good lunch, see you later in here...
Looks like this stock needs some noise....huat ar..
Come ha...today come and short here...
value preposition is good. undervalue without the deal, and the deal is a plus to reach the normalized price. hopefully......
easywin ( Date: 11-Jan-2021 15:22) Posted:
Still at lower price range, grab it.
superstartup ( Date: 11-Jan-2021 11:30) Posted:
UOBKH
Monday , 11 January 2021
Singapore Medical Group (SMG SP) Potential Offer On The Cards Valuation Still Attractive Singapore Medical Group announced on 18 Dec 20 a possible transaction involving the company&rsquo s shares. While discussions are still preliminary, the stock is up 12% since the announcement. Current valuation at 12x 2021F PE is at a sizeable discount to peers&rsquo despite the group&rsquo s strong growth prospects amid recovering healthcare expenditure in Singapore. Maintain BUY on this undervalued healthcare player with a higher PE-based target price of S$0.46
BUY (Maintained) Share Price S$0.33 Target Price S$0.46 Upside 39.4% (Previous TP: S$0.37)
|
|
|
|
1000% agree...
Still at lower price range, grab it.
superstartup ( Date: 11-Jan-2021 11:30) Posted:
UOBKH
Monday , 11 January 2021
Singapore Medical Group (SMG SP) Potential Offer On The Cards Valuation Still Attractive Singapore Medical Group announced on 18 Dec 20 a possible transaction involving the company&rsquo s shares. While discussions are still preliminary, the stock is up 12% since the announcement. Current valuation at 12x 2021F PE is at a sizeable discount to peers&rsquo despite the group&rsquo s strong growth prospects amid recovering healthcare expenditure in Singapore. Maintain BUY on this undervalued healthcare player with a higher PE-based target price of S$0.46
BUY (Maintained) Share Price S$0.33 Target Price S$0.46 Upside 39.4% (Previous TP: S$0.37)
|
|
hahaha, maybe you know the reason why...any way huat ar..
Sorry, 40 cents unlikely to hit by end of today as it is impossible unless the condition is very bullish
Careful2020 ( Date: 11-Jan-2021 14:09) Posted:
50 cents still a long way to go, today is very unlikely to happen not even tomorrow
Invest1 ( Date: 11-Jan-2021 13:39) Posted:
| If everyone buy 50lots, we should be able to break 40 cents today. |
|
|
|
Power up...sitting on profit...👍
Invest1 ( Date: 11-Jan-2021 13:15) Posted:
Last week I already mentioned that it can go much higher...UOBKH follow same....hahaha
superstartup ( Date: 11-Jan-2021 11:30) Posted:
UOBKH
Monday , 11 January 2021
Singapore Medical Group (SMG SP) Potential Offer On The Cards Valuation Still Attractive Singapore Medical Group announced on 18 Dec 20 a possible transaction involving the company&rsquo s shares. While discussions are still preliminary, the stock is up 12% since the announcement. Current valuation at 12x 2021F PE is at a sizeable discount to peers&rsquo despite the group&rsquo s strong growth prospects amid recovering healthcare expenditure in Singapore. Maintain BUY on this undervalued healthcare player with a higher PE-based target price of S$0.46
BUY (Maintained) Share Price S$0.33 Target Price S$0.46 Upside 39.4% (Previous TP: S$0.37)
|
|
|
|
